What does deferred taxes mean?

Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.

Kiniksa Pharmaceuticals International, plc KNSA Deferred Taxes

Deferred Taxes at other companies

Ligand PharmaceuticalsLGND

$13.53M+53.0%

Aurinia PharmaceuticalsAUPH

$9.28M—

AnaptysBio, Inc.ANAB

$0+100%

Ionis PharmaceuticalsIONS

$218K+87.9%

ANI PharmaceuticalsANIP

$2.52M+174%

AlkermesALKS

——

Other financials

Income statement

See full

Revenue$214.3M+55.5%

Gross profit$193.5M+61.3%

Operating income$29.3M+121%

Net income$22.6M+165%

EPS (diluted)$0.27+145%

Balance sheet

See full

Cash & equivalents$190.0M+20.9%

Total debt$9.0M-9.0%

Total equity$605.7M+32.4%

Total assets$825.3M+37.7%

Cash flow

See full

Operating cash flow$50.2M+125%

CapEx$161.0K+62.6%

Free cash flow$50.0M+125%

Valuation

See full

Market cap$4.58B+128%

Profitability

See full

Gross margin89.3%+3.5pp

Operating margin12.4%+10.2pp

Net margin9.7%+7.6pp

FCF margin21.8%+12.2pp

Returns & leverage

See full

Return on equity13.7%+11.3pp

Debt / equity0×0.0×

Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's deferred taxes?: Kiniksa Pharmaceuticals International, plc (KNSA) reported deferred taxes of $4.52M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's deferred taxes changed year-over-year?: Kiniksa Pharmaceuticals International, plc's deferred taxes increased by 51.1% year-over-year, from $2.99M to $4.52M.
What does deferred taxes mean?: Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.